{"id":"NCT05147233","sponsor":"Oculis","briefTitle":"A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery","officialTitle":"A Randomized, Double-masked, Vehicle-controlled Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle in the Treatment of Inflammation and Pain Following Cataract Surgery","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-06-24","primaryCompletion":"2023-06-22","completion":"2023-07-03","firstPosted":"2021-12-07","resultsPosted":"2025-07-11","lastUpdate":"2025-07-11"},"enrollment":241,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Inflammation Eye Pain","Postoperative Cataract"],"interventions":[{"type":"DRUG","name":"OCS-01","otherNames":[]},{"type":"DRUG","name":"Vehicle","otherNames":[]}],"arms":[{"label":"OCS-01","type":"EXPERIMENTAL"},{"label":"Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"This was a randomized, double-masked, vehicle-controlled, Phase 3 study evaluating the efficacy and safety of OCS-01 QD compared to vehicle in the treatment of inflammation and pain following cataract surgery.","primaryOutcome":{"measure":"Absence of Anterior Chamber Cells at Visit 6.","timeFrame":"Day 15","effectByArm":[{"arm":"OCS-01","deltaMin":57.2,"sd":null},{"arm":"Vehicle","deltaMin":24,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":25,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":119},"commonTop":["Eye Pain"]}}